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A B S T R A C T
Closely related bovine alphaherpesviruses 1 (BoHV-1) and 5 (BoHV-5) co-circulate in certain countries, ren-
dering cattle co-infection possible. This is a prerequisite for BoHV recombination. Here, we report the ﬁrst
identiﬁcation of homologous recombination between ﬁeld isolates of BoHV-1 and BoHV-5, two alpha-
herpesviruses belonging to two distinct species with an average genomic similarity of 82.3%. Three isolates of
BoHV-5, previously classiﬁed as subtype “BoHV-5b”, were phylogenetically studied and analyzed via eight PCR
sequencing assays dispersed at regular intervals throughout the genome to discriminate between BoHV-1 and
BoHV-5. In the phylogenetic analysis, diﬀerences of clustering were found in the UL27 gene which encodes the
glycoprotein B (gB). We detected two recombination breakpoints in the open reading frame of the UL27 gene.
We compared the amino acid sequences of the gB of BoHV-1.1 and 1.2, BoHV-5a and recombinant formerly
named BoHV-5b (chimeric gB) and subsequently performed molecular modeling. All structures were alike and,
simultaneously, similar to the chimeric gB. Neutralizing antibodies against BoHV-1, BoHV-5 and recombinant
viruses were analyzed via serum virus neutralization test using polyclonal sera and a monoclonal antibody
against gB to demonstrate an absence of viral escape for both assays.
Our results show that homologous recombination between two related species of ruminant alpha-
herpesviruses can occur in natural ﬁeld conditions. We found three recombinant ﬁeld isolates, previously
classiﬁed as BoHV-5b subtypes, between BoHV-1 and BoHV-5.
1. Introduction
Within the Herpesviridae family, Alphaherpesvirinae is an extensive
subfamily containing numerous viruses of great relevance for both
human and animal health and associated economic production. As re-
gards the latter, bovine herpesvirus 1 (BoHV-1) is the etiological agent
of infectious bovine rhinotracheitis, infectious pustular vulvo-vaginitis,
abortion and balanoposthitis, and it also is an important component of
the bovine respiratory disease complex, causes severe economic losses
and imposes restrictions to international livestock trade. Endemic in
cattle populations worldwide (Raaperi et al., 2014), BoHV-1 co-
circulates with the closely related bovine herpesvirus 5 (BoHV-5) rarely
in Europe, Australia and the USA but with a strong geographical dis-
tribution in South America (Del Medico Zajac et al., 2010).
Nucleotide substitution rates are low in alphaherpesviruses, esti-
mated to lie at around 3 × 10−8 per site per year (Sakaoka et al.,
1994). The overall rate of herpesvirus protein sequence evolution has
been estimated at 3 × 10−9 per amino acid per year (McGeoch et al.,
2000). This is an order of magnitude greater than the evolutionary rate
of mammalian nuclear genes (Shackelton and Holmes, 2004), sug-
gesting that alphaherpesviruses may evolve faster than their hosts.
However, the mutation rate is still low as compared to that of other
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viruses (e.g. RNA viruses), indicating that additional mechanisms must
act together with mutations to mediate herpesvirus evolution (Schynts
et al., 2003). Of these mechanisms, homologous recombination is the
most frequent in herpesviruses, although illegitimate recombination
has also been observed (Rijsewijk et al., 1999; Umene, 1999). Whether
viral recombination in general is driven by mechanistic constraints
associated with genome structures or is selectively favoured as a means
to increase genetic diversity end eliminate deleterious mutations, it is
undisputed that recombination can be considered as an essential
driving force to increase the occurrence of rare but advantageous mu-
tations within a viral species (Thiry et al., 2006). Highlighting the
importance of recombination during herpesvirus history, sequence
analysis has shown strong evidence of past natural homologous re-
combination events in several species, including human (Loncoman
et al., 2017; Norberg et al., 2007, 2006, 2004; Peters et al., 2006) and
animal (Hughes and Rivailler, 2007; Lee et al., 2011, 2015; Pagamjav
et al., 2005) alphaherpesviruses.
In vitro and in vivo, herpesvirus recombination has been studied
between distinguishable strains of herpes simplex virus 1 or 2 (HSV-1
and HSV-2) (Brown et al., 1992; Nishiyama et al., 1991), varicella-
zoster virus (VZV) (Dohner et al., 1988), pseudorabies virus (PRV)
(Dangler et al., 1993; Glazenburg et al., 1994; Henderson et al., 1990),
feline herpesvirus 1 (FeHV1) (Fujita et al., 1998) and BoHV-1/5 (Del
Medico Zajac et al., 2010; Meurens et al., 2004; Schynts et al., 2003;
Schynts et al., 2001). Interspecies recombinants between BoHV-1 and
BoHV-5, at a reduced degree of average similarity (82.3%), were ob-
tained under in vitro co-infection by Meurens et al. (2004). More re-
cently, these recombinants were characterized regarding both their
genome structure and their virulence in natural hosts (Del Medico Zajac
et al., 2011, 2009) and showed attenuated replication characteristics
and established latency in the natural host.
While natural homologous recombination has been described in
diﬀerent species of alphaherpesviruses, it occurs most commonly as
intraspecies recombination. Interspecies recombination however ap-
pears to be rare with a single reported detection between equine her-
pesviruses 1 and 4 in ﬁeld samples (Pagamjav et al., 2005). It has not
yet been reported between human alphaherpesviruses or other animal
alphaherpesviruses.
The examination of natural intra- and interspecies recombination of
bovine herpesviruses is especially relevant with respect to the wide-
spread use of attenuated BoHV-1 vaccines (Muylkens et al., 2006; van
Drunen Littel-van den Hurk, 2007) and risks to animal health posed by
the potential of recombination between bovine herpesviruses and live
attenuated vaccine strains. While live attenuated vaccines against
BoHV-1 are not used in Argentina, the co-circulation of BoHV-1 and
BoHV-5 presents a unique opportunity for co-infection and subsequent
recombination between strains.
In this work, we a report the ﬁrst molecular detection of interspecies
recombinant ﬁeld isolates between two alphaherpesviruses BoHV-1 and
BoHV-5, previously isolated in Argentina and known as BoHV-5 sub-
type b (Maidana et al., 2013).
2. Materials and methods
2.1. Virus population samples and cell culture
Viruses used in this study were propagated in Madin Darby bovine
kidney (MDBK) cells and viral stocks were produced after infection of
MDBK cells at a multiplicity of infection (MOI) of 0.01, as previously
described (Romera et al., 2000) (Table 1). MDBK monolayers were
grown in 12-well plates, and infected with 1:10 serial dilutions of the
isolates A663, 166/84 (Maidana et al., 2011) and 674/10 (Maidana
et al., 2013). After incubation for 2 h at 37 °C, viral inocula were re-
moved by washing. To detect the progeny generated speciﬁcally by
each viral particle, 2 ml carboxymethyl cellulose (CMC)/FBS (7,5 g/L
CMC, 480 ml/L MEM-D 2X, 20 ml/L SFB) semisolid overlay were added
to each well. Plates were incubated for 72 h at 37 °C. Finally, several
(n = 30) isolated lysis plaques were selected and replicated in-
dividually to isolate and amplify a single viral clone.
2.2. PCR, DNA sequence and phylogenetic studies
Eight diﬀerent sets of primers, spread along the genome were used
in this study. They served to amplify regions located in the unique long
(UL) region (UL41, UL40, UL29, UL28, UL27 and UL22) (Del Medico
Zajac et al., 2009; Maidana et al., 2011) and the short (US) region (US6
and US8) as previously described by (Thiry et al., 2007) (Table 1).
Nucleotide sequences of the isolates were edited and analyzed with
BioEdit version 7.0.5.3 (Hall et al., 1999). Alignments were performed
with Clustal W. MEGA 5.0 software (Tamura et al., 2011). A phyloge-
netic inference was performed using the MEGA version 5 software
package based on UL27 and US6, which are conventionally used to
study the phylogenetic relationships amongst ruminant alpha-
herpesviruses. Tree topology was constructed via maximum composite
likelihood method with the Tamura and Nei model (1000 replicate
bootstrap values).
2.3. Recombination analysis
The complete UL27 gene of the three BoHV5b isolates, responsible
for the diﬀerential clustering in the phylogenetic analysis, was ampli-
ﬁed by PCR and sequenced. Subsequently, genetic recombination was
analyzed using a sliding-window genetic diversity plot (Simplot soft-
ware version 3.5.1 available at http://sray.med.som.jhmi.edu/
SCRoftware) (Lole et al., 1999) and the Recombinant Detection
Program (RDP) (Martin et al., 2015), version 3, available at http://
darwin.uvigo.es/rdp/rdp.html.
2.4. Amino acid sequence comparison
Amino acid (aa) sequences for the entire gB were compared between
the BoHVs. Alignments and sequence identity matrices were performed
with Clustal W. MEGA 5.0 software (Tamura et al., 2011). To evaluate
potential antigenicity changes in gB due to limited aa sequence varia-
tions in BoHV1.2b, BoHV5a and BoHV5b isolates, we performed epi-
tope predictions of these sequences using BepiPred (http://www.iedb.
org/). This program predicts the location of linear B-cell epitopes using
a combination of a hidden Markov model and surface propensity scale
method. The residues with scores above the threshold (1.5) are pre-
dicted to be part of an epitope. The number of epitopes predicted in
recombinant gB was compared to that of the parental viruses.
2.5. Molecular modeling
Structural models of gB from BoHV-1.2b, BoHV-5 and ﬁeld isolates
were constructed with the program SWISS-MODEL (http://swissmodel.
expasy.org/; (Guex and Peitsch, 1997; Kiefer et al., 2009; Schwede
et al., 2003), using the HSV-1 gB crystal structure 3NW8 as template
Table 1
Bovine herpesvirus isolates and reference strain used in this study.
Viruses Strain Subtype Reference
BoHV1 Cooper 1.1 d’Oﬀay et al. (1993)
K22 1.2b
688/10a 1.2b
BoHV5 SV507/99 a Delhon et al. (2003)
06/13a a
A663 b Carrillo BJ et al. (1983)
166/84 b Maidana et al. (2011)
674/10 b
a Field isolates with low passage number used in in vitro assays.
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(Stampfer et al., 2010). Overall composite quality scores (Benkert et al.,
2011) and estimated residue errors were evaluated. The models ob-
tained were compared to each other, and also to the HSV-1 gB crystal
structure 3NW8 (Stampfer et al., 2010), accessed via the Research
Collaboratory for Structural Bioinformatics protein databank (RCSB
PDB) (http://www.pdb.org; Berman et al., 2000) (Heldwein et al.,
2006).
2.6. Lysis and infection plaque size assays
MDBK monolayers grown in 6 wells culture plates were inoculated
with the recombinant isolates (A663, 166/84 and 674/10) and the
possible parental viruses (BoHV1.2b and BoHV5a) at tenfold serial di-
lutions. The viruses used in these tests had a low number of passages in
cell culture; to maintain this condition were used as parental strains
ﬁeld isolates previously characterized by molecular biology (688/
10 = BoHV1.2b, 06/13 = BoHV5a). After 2 h of incubation at 37 °C,
the inoculum was removed and 2 ml of carboxy methyl cellulose (CMC)
1.5% FCS per well were added. Plates were incubated at 37 °C for 72 h.
For the lysis plaque size assay, cells were ﬁxed with 10% formaldehyde
for 10 min at room temperature, stained with violet crystal (1% violet
crystal, 10% ethanol in PBS) for 20 min and washed in PBS. For each
virus, 30 isolated and randomly selected lysis plaques were observed
with an optical microscope and photographed. For the infection plaque
size assay, cells were ﬁxed with 4% paraformaldehyde (PFA) for 10 min
at room temperature. After washing in PBS, cells were incubated for 1 h
at 37 °C with an anti IBR-FIT-C conjugated antibody (USBilogical life
sciences, U.S.A) diluted in PBS and then cells were washed twice in PBS.
For each virus, 20 isolated and randomly selected infectious foci were
observed with a ﬂuorescent microscope and photographed. The
photographs were analyzed with ImageJ software in order to calculate
lysis and infection plaques surfaces. For both assay statistical analysis
was performed using one way ANOVA and the Tukey test.
2.7. Serum neutralization assay (SN) and virus neutralization (VN) assays
To study the rate of neutralization, we performed a serum-virus
neutralization test (SN) with constant polyclonal serum and variable
virus. This assay was carried out against BoHV-1, BoHV-5 and the re-
combinants in 96-well cell culture plates.
Sera against BoHV-1, BoHV-5 and the recombinant viruses were
obtained from experimental infections assays in cattle, as previously
reported (Ladelfa et al., 2011; Romera et al., 2014). Viruses were ten-
fold diluted, from 10−1 to 10−9 in Earlés Minimum Essential medium
(E-MEM). Sera were mixed with the virus dilutions in an equal volume
in a 96-well microtiter plate. After an incubation period of 2 h at 37 °C,
the mixed volume was added to a MDBK cell monolayer. After a further
incubation of 72 h, endpoint virus titers were calculated using the
Reed–Muench method.
Additionally, a VN assay using constant polyclonal serum m(Ab)
anti gB- and the varying virus strains BoHV-1.1, 1.2a, 1.2b, 5a and 5b
(recombinant isolates) was performed. As explained above, tenfold
virus dilutions, from 10−1 to 10−9, were mixed with a 1:100 dilution of
m(Ab) anti gB, in a 96-well microtiter plate. After incubation at 37° C,
the m(Ab)-virus mix was added to a MDBK cell monolayer. Endpoint
neutralization virus titres were calculated as described above. For both
assays, the neutralization index was calculated as the ratio between
virus titer and virus neutralization titer, both with polyclonal serum
and monoclonal antibody, respectively.
Fig. 1. Nucleotide phylogenetic analysis based on gB and gD gene fragments. Maximum likelihood phylogenetic trees were generated using alignments of nucleotide sequences of the
UL27 (A) and US4 (B) fragment genes. One hundred bootstrap replicates were used to assess the signiﬁcance of the tree topologies and the number of replicate trees containing each
speciﬁc branch in the consensus tree is shown next to that branch. The recombinant viruses are indicated in bold, marked with a box and joined by lines between the two phylogenetic
trees showing diﬀerent clustering with BoHV-1 or BoHV5 depending on the analyzed gene.
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3. Results
3.1. The diﬀerential clustering of gB and gD genes suggests that isolates
A663, 166/84 and 674/10 are recombinant. Multiple PCR sequencing
assays reveal the background of recombinant viruses to originate from
BoHV5
Phylogenetic analyses demonstrate that the three isolates A663,
166/84 and 674/10, previously classiﬁed as BoHV-5 subtype b, cluster
diﬀerently with BoHV-1 and BoHV-5 depending on the genes encoding
glycoprotein B (gB) or D (gD), indicating these viruses are recombinants
between BoHV-1 and BoHV-5 (Fig. 1).
To characterize the genomic background of the recombinants, we
used eight PCR sequencing assays distributed along the whole genome.
The ampliﬁed fragments displayed diﬀerences discriminating BoHV-1
from BoHV-5. Six fragments from genes localized within the unique
long (UL) region (UL53, UL41, UL40, UL29, UL28, UL27 and UL22) and
two from genes of the unique short (US) region (US6 and US8) were
ampliﬁed. The alignment of genomic stretches allowed diﬀerentiation
of the virus species at each selected locus. The resulting amplicons
diﬀered from sequences of BoHV-1 and BoHV-5 via several distinct
point mutations, deletions, and insertions. The analysis of the loci and
the observed divergences between the sequences allowed an accurate
discrimination between BoHV-1 and BoHV-5.
3.2. Two crossover points localized within the gB gene in the three
recombinant viruses
Based on the analyzed sequences, we located recombination sites
within each of the recombinant viruses. We detected two possible
crossover points, as evidenced during alignment with the parental
strain by a disruption in the sequence. In 42 ﬁeld isolates of BoHV-1,
speciﬁc markers were identiﬁed 17 bp upstream of the 5′ end of the
UL27 gene. Downstream of this region, changes were only detected in
isolates classiﬁed as BoHV5b. In view of this, we suggest that the re-
combination event occurred in the 18 bp stretch at the 5′ region of the
UL27 gene (nt 56019–556037, based on BoHV1 sequence, nt
56565–56583 based on BoHV-5). At the other crossover point (CO), the
identiﬁcation of a 14 bp of homology downstream of BoHV1-speciﬁc
markers allowed identiﬁcation of the recombination site within the
UL27 gene (nt 58269–58283 based on BoHV1, nt 58839–58853 based
on BoHV-5). The two regions of homologies share common features
(Fig. 2) in that both are relatively short (less than 45 bp) and both
contain a stretch of 35 successive nucleotides with a high GC content
(90%). In light of these ﬁndings, we investigated the complete gene
sequence in search of other recombination points.
The complete UL27 gene was ampliﬁed from the three virus isolates
A663, 166/84 and 674/10 by PCR aand deposited in the GenBank
(Accession numbers: KU992438, KU992439 and KU992440).
Amplicons were cloned into pUC18 plasmids and sequenced in both 5′
and 3′ direction. The results were conﬁrmed by Simplot analysis based
on the complete UL27 gene.
Based on the sequence of the UL27 gene of BoHV5
(YP003662497.1), the ﬁrst crossover point is extended from nt position
475 to 491 and the second crossover point is lies between positions
2749 to 2761, resulting in a recombination fragment of 2286 bp. This
fragment shows 100% identity to BoHV-1.2b (Fig. 2).
The total number of aa between the recombinant and parental
strains diﬀers somewhat. The aa sequences of the three recombinant
gps (gB chimeric) are identical to those of the parental strains, except
for a change shared by all three chimeras, where alanine is swapped for
threonine at position 870, and a second change only in chimera 166/84,
where glutamic acid is replaced by alanine at position 667.
3.3. Molecular modeling, construction, and structural model analysis of
recombinant gB reveals a structural model of a parent-like chimeric
glycoprotein
Structural models of gB of BoHV-1.1, BoHV-5 and the recombinant
isolates 166/84, 674/10 and A6663 were made with Swiss Model
(Arnold et al., 2006; Guex and Peitsch, 1997; Kiefer et al., 2009;
Schwede et al., 2003), using the crystal structure of HSV-1 gB as tem-
plate (pdb code: 3NW8, (Stampfer et al., 2010) HSV-1 vs BoHV-1 or
BoHV–5∼ 50% identity). The structural models cover nearly∼73% of
the protein sequences (residues 121-763 in the chimera 166/84). The N
terminal and C terminal regions (residues 1–120 and 764–955 in the
chimera 166/84, respectively) have no available structural template
and seem to have large amounts of disorder as predicted by the program
PONDR (Fig. S1) (Romero et al., 2001). The structural models obtained
are all similar to each other (Fig. 3a), and also to previously reported
BoHV-1 and BoHV-5 models (Levings and Roth, 2013). The only ex-
ception is a region of domain II, enriched in proline residues, which is
absent in the template structure and had to be reconstructed (Fig3a).
The sequence variability (residues485-525 in BoHV-1 gB, 492–539 in
BoHV-5 gB, and 492–532 in the 166/84 gB chimera), lack of stable
structure in the template and low quality value of this region in the
models (Fig. S2), is due most probably to local conformational ﬂex-
ibility.
Fig. 4 shows the aa sequence alignment between the recombinant
166/84 gB chimera, the parental BoHV-1 and BoHV-5 gB, and HSV-1
gB, used as template for the structural models. Similarities and diﬀer-
ences between the chimeras and the parental sequences are highlighted.
The central region of the chimera corresponds to BoHV-1 (residues
∼197–901, ∼75% of the sequence), whereas the N terminal and C
terminal regions (residues ∼1–196 and ∼902–939, respectively) cor-
respond to BoHV-5 (21% and 4% of the sequence, respectively). The
central region encompass most parts of all domains of the glycoprotein,
the N-terminal region contributes a small part of domains 1, 2, 3 and 4
and the C terminal region encompass the last part of the cytoplasmic
domain (Fig. 4). Residues identical to BoHV-1 or BoHV-5 gB in the
recombinant chimeras are highlighted in Fig. 4 and also mapped in the
structural model of the chimera 166/84 (Fig. 3b). This analysis shows
that the domain loop II is enriched in residues that correspond to
BoHV1. The prediction of linear epitopes for BoHV-1, BoHV-5 and the
166/84 chimera, was carried out using the program Bepipred (Larsen
et al., 2006). Predicted epitopes were labeled on the aa protein se-
quences (Fig. 4) and mapped on the structural model of the 166/84 gB
chimera (Fig. 3c).
3.4. The in vitro characterization determined that although the genetic
background is similar to BoHV5, the recombinant viruses show cell-cell
dispersion similar to BoHV1 indicating that gB would have a preponderant
role in this function
The lysis plaque size assay represents an indirect measure of viral
cell-to cell spread and a direct measure of viral lytic potential. During
plaque size comparison of parental and recombinant strains, only
showed statistically signiﬁcant diﬀerences, plaques generated by one of
the parental virus (BoHV5a) and one of the recombinant viruses (166/
84) (p > 0.005) (Fig. 5a).The infection plaque assay considers both
the cells lysed by the virus and also the infected cells expressing viral
antigens on their surface, being a direct method to study cell-to-cell
diﬀusion. Comparison between BoHV5a-generated infection plaques
and recombinant strains showed signiﬁcant diﬀerences (p > 0.005),
the largest plaques being generated by the major parental (06/
13 = BoHV5a) than those generated by all recombinant strains
(Fig. 5b).
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3.5. Recombinant viruses are recognized by bovine sera against diﬀerent
subtypes of BoHV-1 and BoHV-5 and also by a monoclonal antibody used in
a BoHV-1 diagnostic kit
A serum neutralization assay using diﬀerent polyclonal sera against
each of the parental viruses and the recombinant viruses showed re-
cognition at diﬀerent degrees (Table 2). The VN assay with the parental
virus and the recombinant isolates using the monoclonal antibody
against gB (used in the Serelisa IBR/IPV gB Ab mono blocking kit) re-
cognizes all recombinant viruses.
4. Discussion
Here, we provide the ﬁrst evidence of natural interspecies re-
combination between two related ruminant alphaherpesviruses (BoHV-
1 and BoHV-5), at a reduced degree of genomic similarity (82.3%
average similarity). Based on phylogenetic analysis, multiple PCR se-
quencing assays and sequence and genetic recombination analysis using
a sliding-window genetic diversity plot (Simplot), we found three re-
combinant ﬁeld isolates between BoHV-1 and BoHV-5. Our ﬁndings
indicate that BoHV-5 subtype b, whose current classiﬁcation by REA is
based on the analysis of the three examined ﬁeld isolates, should rather
be considered as a natural recombinant of BoHV-5 subtype a and BoHV-
1 subtype 1.2b. The recombination event causes the disappearance of a
restriction site for enzyme BstEII, generating a typical restriction pat-
tern responsible for the classiﬁcation as BoHV-5 subtype “b”.
We identiﬁed and sequenced two homologous recombination sites
in three ﬁeld isolates. Concurring with our previous observations (Del
Medico Zajac et al., 2009), these new ﬁndings contrast with the cur-
rently proposed double-strand break repair model for homologous
Fig. 2. (A) Nucleotide identity plot of UL27 gene
compared with BoHV1.2b and BoHV5a reference
strains, the recombinant A663, 166/84 and 674/10
strains. Nucleotide positions are reported on the X-
axis and percent similarity on Y-axis. (B) Multiple
alignment of sequence of UL27 in comparison to the
corresponding sequences of BoHV1.2b, BoHV5a and
recombinant viruses.
Fig. 3. a) Superposition of the structural models of
gB from BoHV1 (red), BoHV5 (blue) and re-
combinant chimera 166/84 (green), obtained using
the crystal structure of HSV1 (pdb: 3NW8) as tem-
plate. b) Trimeric structural model of the re-
combinant 166/84 chimera. The residues are colored
by their similarity to the BoHV1 and BoHV5 se-
quences. Residues identical to both BoHV1 and
BoHV5 are colored green. Residues only identical to
BoHV1 are represented as red VDW spheres, and
those only identical to BoHV-5 are represented as
blue VDW spheres. c) Analysis of the 166/84 chi-
mera with the program Bepipred. The linear epitopes
predicted with the program are represented as purple
VDW spheres on chain A (green) of the trimeric
structural model of the chimera. (For interpretation
of the references to colour in this ﬁgure legend, the
reader is referred to the web version of this article.)
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Fig. 4. Multiple amino acid sequence alignment of gB from HSV1, BoHV1, BoHV5 and the recombinant chimera 166/84. Residues area colored by their similarity to the sequences of
BoHV1 and BoHV5. Residues only identical to BoHV1 are colored red, whereas those only identical to BoHV5 are colored blue. The boxes represent the regions with structure in the
crystal structure of HSV1 gB (pdb code 3nw8) used as template for the structural models. Regions with no structure in the template encompass the N-terminal, loop of domain II and C-
terminal regions of the protein. Among these regions, only the one corresponding to the domain II was reconstructed for the models. The black boxes represent the domains according to
the structure of HSV-1 gB used as annealed and the white arrows indicate recombination points. The residues shown as underlined bold letters, represent the ones predicted as linear
epitopes with the Bepipred program. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 5. In vitro characterization. A: Lysis plaque
generated by recombinant and parental strains. Error
bars represent standard deviation. BoHV5a and 166/
84 is signiﬁcantly diﬀerent (Tukey test, P < 0.05).
B: Infection plaque generated by recombinant and
parental strains. Error bars represent standard de-
viation. BoHV5a and all recombinant strains are
signiﬁcantly diﬀerent (Tukey test, P < 0.05).
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herpesvirus recombination (Thiry et al., 2005; Umene, 1999), as the
region of homology detected in the two recombination sites is two times
smaller than the minimal region shown to be actively involved in the
synapsis formed during RecA-mediated homologous recombination
(van der Heijden et al., 2008). Our previous report (Del Medico Zajac
et al., 2011) showed that recombination occurred within small frag-
ments of perfect sequence homology where only 38 and 44 bp of
homology were detected in both recombination sites. In this work,
natural recombination also occurred within a short fragment of
homology of 14 to 18 bp detected around both recombination sites
(Fig. 2). Furthermore, our results support the postulate by (Meurens
et al., 2004) stating that the occurrence of a ﬁrst recombination event
positively inﬂuences the occurrence of a second recombination event in
a neighboring region. To explain the generation of these recombinant
viruses, two hypotheses could be put forth; either both recombination
points originated in a single recombination event or resulted from a
double recombination event in simple recombinant genomes.
Since both recombination events were located within the chimeric
gB sequence (encoded by 80% of the BoHV-1 and 20% of the BoHV-5
sequence), the conserved transmembrane gB glycoprotein was further
investigated by molecular modeling.
Levings et al. (2015) report that, based on the crystal structures of
HSV1 (3NW8), BoHV-1 and BoHV-5 gB structures are similar. Here we
show that models of chimeric gB of recombinant viruses are similar to
gB parental structures. In the chimera, we observed the same domain
construct as characterized for HSV-1 gB (Heldwein et al., 2006). In
addition, chimeric gB shows a combination of linear epitopes of par-
ental gBs, while not possessing own linear epitopes. Based on these
studies, we can conclude that the recombination events did not aﬀect
the three-dimensional structure of the glycoprotein of the recombinant
viruses, and can further infer that vital functions attributed to the
glycoprotein were not aﬀected. However, the in vitro characterization
performed here suggests that all recombinant strains possess decreased
capacities for cell-to-cell spread compared to the parental strain (BoHV-
5a) but not to the other parental virus (BoHV1.2b) indicating that
perhaps in this biological characteristic the recombinant viruses behave
similarly to the BoHV1. These results should be further elucidated once
the complete genetic background of the recombinant strains is analyzed
since the possibility of other recombination points with an impact on in
vitro and in vivo behavior of these viruses cannot be ruled out.
In this study, the immunogenicity of these recombinant viruses was
investigated via serum neutralization. Polyclonal sera reacted against
the diﬀerent virus species and their subtypes, supporting the widely
proposed hypothesis of cross-neutralization between diﬀerent ruminant
alphaherpesviruses. In view of the observed diﬀerences in the degree of
neutralization for the recombinant viruses and their failure in escaping
the classical serological test for ruminant alphaherpesviruses, it is
possible that they cannot however entirely escape immunity induced by
vaccines or outbreaks of BoHV-1.
In South American countries, especially Brazil and Argentina, where
BoHV-1 and BoHV-5 co-circulate and vaccination is not obligatory (Del
Medico Zajac et al., 2009; Maidana et al., 2014, 2013), cattle can easily
be co-infected with diﬀerent virus species. Subsequent interspecies re-
combination can then occur, generating recombinant viruses with un-
known biological characteristics. In our study, three BoHV strains,
previously classiﬁed as BoHV-5 subtype b, have been retrospectively
identiﬁed as recombinants. Two of these were isolated in the early 80′s
during an outbreak of typical nervous BoHV-5 involving calf death. The
third was isolated in 2010 from the semen of an asymptomatic adult
bull, indicating that the recombinant viruses can successfully spread
and be maintained within the cattle population. The latter observation
is in apparent contrast to the initial attenuation observed for in vitro-
generated recombinant BoHV-1/5 viruses (Del Medico Zajac et al.,
2011). While it is unsurprising that a recombination event may initially
attenuate a novel chimeric strain (genome instabilities may ensue), it
appears that this does not necessarily exclude its circulation in vivo. We
could postulate that a less virulent, recombinant BoHVs might pose less
of a threat to the immune system and evade recognition, immune
control and elimination allowing persistence in a latent state and cir-
culation in the ruminant population at low quantities.
The detection of natural recombination in alphaherpesviruses varies
from limited or absent in FeHV-1 and equid herpesvirus 1 (EHV-1) (Vaz
et al., 2016a; Vaz et al., 2016b) to widespread in HSV-1, EHV-4 and
gallid herpesvirus 1 (GaHV-1) (Kolb et al., 2015; Lee et al., 2013; Lee
et al., 2012; Szpara et al., 2014; Vaz et al., 2016a) suggesting that the
contribution that recombination makes to genomic diversiﬁcation and
evolution in alphaherpesviruses varies across the diﬀerent virus species
(Loncoman et al., 2017).
Amongst ruminant alphaherpesviruses, homologous recombination
has been shown to occur between viruses with high (BoHV-1 subtypes)
(Muylkens et al., 2009; Schynts et al., 2003) as well as low genomic
similarity (BoHV-1 and 5) (Meurens et al., 2004; and data reported
here. The generation of novel recombinant viruses between ruminant
alphaherpesviruses may also occur in regions, where, in new mixed
production systems, two or more ruminant species coexist, presenting
conducive environments for viral co-circulation. In Argentina, these
conditions are fulﬁlled in the northwestern and southern regions where
diﬀerent species of ruminants share the same habitat. From the gen-
eration of natural recombinants of co-circulating strains as shown here,
potential risks of recombination between circulating strains may be
extrapolated.
In conclusion, we identify recombinant ruminant alpha-
herpesviruses and provide evidence of the existence of natural re-
combinants and recombination events within distinct viral species in
the subfamily Alphaherpesvirinae. Special attention should be paid to
natural recombination between bovine herpesvirus strains as it can
potentially increase the complexity of diﬀerential diagnosis and un-
known pathogenesis of BoHV-1 infections, augment the risk of vaccine-
induced immunity escape and lead to the generation of vaccine-strain
recombinants. This highlights the importance of combining studies that
examine recombination in experimental settings with those that in-
vestigate recombination in ﬁeld isolates from naturally infected hosts. It
is clear that further examination of natural recombination in bovine
alphaherpesviruses at a population level is merited.
Acknowledgements
The authors wish to thank Lorène Dams for her excellent technical
assistance (University of Liege, Belgium). This study was ﬁnancially
supported by the Agencia Nacional de Promoción Cientíﬁca y
Tecnológica (ANPyCT), Ministerio de Ciencia, Tecnología e
InnovaciónProductiva, Argentina (BID-PICT N° 1460); INTA (PNSA
1115054 and 1115055) and FNRS-CONICET (Res. N° 3334/14)
Table 2
Speciﬁc and non-speciﬁc reactions of recombinant viruses in SN assays by four BoHV1/5-




LA K22 N569 A663 CC
Polyclonal sera α-BoHV1.1 +++ ++ +++ −/+ –
α-BoHV1.2b ++ +++ ++ ++ –
α-BoHV5a ++ ++ +++ ++ –
α-BoHV5
recom.
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